Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development
- PMID: 35154247
- PMCID: PMC8829113
- DOI: 10.3389/fgene.2021.794476
Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development
Abstract
Background: The 5α-reductase type 2 deficiency (5α-RD2) is a specific form of disorder of sexual development (DSD). Pathogenic variants in the SRD5A2 gene, which encodes this enzyme, are responsible for 46,XY DSD. Objective: The objective of the study was to investigate the genetic etiology of 46,XY DSD in two Mexican families with affected children. Materials and methods: The SRD5A2 gene of the parents and affected children was screened in both families via polymerase chain reaction amplification and DNA direct sequencing. The role of genetic variants in enzymatic activity was tested by site-directed mutagenesis. Results: Subject 1 presented two variants: p.Glu197Asp and p.Pro212Arg. Subject 2 was homozygous for the variant p.Glu197Asp. The two variants were reported in early studies. The directed mutagenesis study showed that the p.Glu197Asp and p.Pro212Arg variants lead to a total loss of enzymatic activity and, consequently, abnormal genitalia development in the patients. Conclusion: These results suggest that p.Glu197Asp and p.Pro212Arg are pathogenic variants that lead to the phenotypic expression of DSD. 5α-RD2 is of extreme importance not only because of its frequency (it is rare) but also because of its significance in understanding the mechanism of androgen action, the process of sexual differentiation, and the factors that influence normal sexual behavior.
Keywords: 46.XY; 5-alpha-reductase deficiency; dihydrotestosterone; testosterone; undefined genitalia.
Copyright © 2022 María Guadalupe, Katy, Charmina, Vihko and Marta.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Novel non-synonymous and synonymous gene variants of SRD5A2 in patients with 46,XY-DSD and DSD-free subjects.PLoS One. 2025 Mar 5;20(3):e0316497. doi: 10.1371/journal.pone.0316497. eCollection 2025. PLoS One. 2025. PMID: 40043094 Free PMC article.
-
Spectrum of Pathogenic Variants in SRD5A2 in Indian Children with 46,XY Disorders of Sex Development and Clinically Suspected Steroid 5α-Reductase 2 Deficiency.Sex Dev. 2019;13(5-6):228-239. doi: 10.1159/000509812. Epub 2020 Sep 5. Sex Dev. 2019. PMID: 32894851
-
The Molecular Basis of 5α-Reductase Type 2 Deficiency.Sex Dev. 2022;16(2-3):171-183. doi: 10.1159/000525119. Epub 2022 Jul 6. Sex Dev. 2022. PMID: 35793650 Review.
-
Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46,XY disorder of sex development.Ital J Pediatr. 2022 Mar 24;48(1):47. doi: 10.1186/s13052-022-01243-4. Ital J Pediatr. 2022. PMID: 35331321 Free PMC article.
-
Practical approach to steroid 5alpha-reductase type 2 deficiency.Eur J Pediatr. 2011 Jan;170(1):1-8. doi: 10.1007/s00431-010-1189-4. Epub 2010 Mar 28. Eur J Pediatr. 2011. PMID: 20349245 Review.
Cited by
-
Genetic control of typical and atypical sex development.Nat Rev Urol. 2023 Jul;20(7):434-451. doi: 10.1038/s41585-023-00754-x. Epub 2023 Apr 5. Nat Rev Urol. 2023. PMID: 37020056 Review.
-
Novel non-synonymous and synonymous gene variants of SRD5A2 in patients with 46,XY-DSD and DSD-free subjects.PLoS One. 2025 Mar 5;20(3):e0316497. doi: 10.1371/journal.pone.0316497. eCollection 2025. PLoS One. 2025. PMID: 40043094 Free PMC article.
-
The Genotype-Phenotype Correlation in Human 5α-Reductase Type 2 Deficiency: Classified and Analyzed from a SRD5A2 Structural Perspective.Int J Mol Sci. 2023 Feb 7;24(4):3297. doi: 10.3390/ijms24043297. Int J Mol Sci. 2023. PMID: 36834714 Free PMC article.
-
Molecular Characterization of Steroid 5 Alpha-Reductase 2 (SRD5A2) Gene Variant in Indian Patients with Disorder of Sexual Development.Arch Sex Behav. 2025 Aug 21. doi: 10.1007/s10508-025-03197-0. Online ahead of print. Arch Sex Behav. 2025. PMID: 40839185
References
-
- Ahmed S. F., Achermann J. C., Arlt W., Balen A., Conway G., Edwards Z., et al. (2016). Society for Endocrinology UK Guidance on the Initial Evaluation of an Infant or an Adolescent with a Suspected Disorder of Sex Development (Revised 2015). Clin. Endocrinol. (Oxf) 84, 771–788. 10.1111/cen.12857 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources